Europe's Leading Nanoelectronics Research Center Announces Bilateral Cooperation with Kaneka Corporation

IMEC, Europe's leading nanoelectronics research center, and Kaneka Corporation, the Japanese leading manufacturer of chemical specialties and solar cells, have announced a bilateral cooperation. Under the agreement, Kaneka will incorporate its European Photovoltaics Laboratory at IMEC in Leuven, Belgium. Working in IMEC's facilities and collaborating with IMEC's experts, this will allow Kaneka to further improve its current thin-film solar cells and to develop next generation cells.

Dr. Kenji Yamamoto, Kaneka’s General Manager Photovoltaic and Thin Film Device Research Laboratories and Dhr. Luc Van den hove, IMEC's President and CEO

This agreement fits in the strategy of Kaneka to examine the expansion of its solar cell manufacturing capacity to 1 Giga Watt by 2015. The decision to establish a European lab was motivated by the need to have a presence, and in future also a production facility, close to the rapidly growing European PV market. “IMEC was chosen as the preferred R&D partner because of its longstanding expertise and excellent track-record in photovoltaics, and because of its unique knowledge and capabilities in materials processing and photonics;” says Kaneka Corporation's President Kimikazu Sugawara.

Luc Van den hove, President and CEO of IMEC, states: “We are extremely happy that Kaneka chooses IMEC as its key partner for its new solar cell research. It emphasizes the prominent role of IMEC in the photovoltaics domain.”

Kaneka's European Photovoltaics Laboratory will be the first R&D lab of a Japanese solar cell manufacturer outside of Japan. Under the agreement, a team of engineers of Kaneka and IMEC will install and operate Kaneka equipment in IMEC's photovoltaics labs. Dr. Kenji Yamamoto, who will be managing the laboratory, says: “By closely collaborating with IMEC's research team we will enhance Kaneka's current thin-film solar cells and develop a new industrial hetero-junction solar cell technology.”

To enhance Kaneka's amorphous silicon microcrystalline silicon (a-Si/uc-Si) solar cells, IMEC's silicon wafer process and device technology and its expertise in optics, micromachining and photonics will be combined. The cooperation will result in a new industrial a-Si:H hetero-junction based high-efficiency solar cell technology, with an envisaged efficiency of beyond 20% for large cells in an industrial proces.

“This collaboration with Kaneka is an important research activity complementary to the silicon photovoltaics industrial affiliation research program running at IMEC;” added Dr. Jef Poortmans, IMEC's Photovoltaics Program Director.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    IMEC. (2019, March 18). Europe's Leading Nanoelectronics Research Center Announces Bilateral Cooperation with Kaneka Corporation. AZoNano. Retrieved on April 24, 2024 from https://www.azonano.com/news.aspx?newsID=13626.

  • MLA

    IMEC. "Europe's Leading Nanoelectronics Research Center Announces Bilateral Cooperation with Kaneka Corporation". AZoNano. 24 April 2024. <https://www.azonano.com/news.aspx?newsID=13626>.

  • Chicago

    IMEC. "Europe's Leading Nanoelectronics Research Center Announces Bilateral Cooperation with Kaneka Corporation". AZoNano. https://www.azonano.com/news.aspx?newsID=13626. (accessed April 24, 2024).

  • Harvard

    IMEC. 2019. Europe's Leading Nanoelectronics Research Center Announces Bilateral Cooperation with Kaneka Corporation. AZoNano, viewed 24 April 2024, https://www.azonano.com/news.aspx?newsID=13626.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.